Efficacy and Safety of Intravenous Thrombolysis Beyond 4.5 Hours in Ischemic Stroke: A Systematic Review and Meta-Analysis
<b>Background</b>: Intravenous thrombolysis (IVT) is the standard treatment for ischemic stroke within 4.5 h of symptom onset. However, a significant proportion of patients present beyond this window. This study aims to evaluate the efficacy and safety of IVT beyond the 4.5 h window in s...
Saved in:
Main Authors: | Muhammad Ahmad, Chavin Akalanka Ranasinghe, Mais Omar Abu-Sa’da, Durga Prasad Bhimineni, Muhammed Ameen Noushad, Talal Warsi, Ahmad Mesmar, Munikaverappa Anjanappa Mukesh, Sagar K. Patel, Gabriel Imbianozor, Ali Mustansir Bhatty, Ahmad Alareed, Quratul Ain, Eeshal Zulfiqar, Mushood Ahmed, Raheel Ahmed |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/15/14/1812 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01) -
RISKS AND BENEFITS OF REPERFUSION STRATEGIES IN ACUTE MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION
by: T. M. Poponina, et al.
Published: (2010-10-01) -
Clinical effectiveness of thrombolytic therapy with alteplase and double antiplatelet therapy in acute myocardial infarction
by: D. N. Kuznetsov, et al.
Published: (2011-12-01) -
Plasminogen activators in acute management of thrombosis
by: E. O. Taratukhin
Published: (2013-06-01) -
Efficacy of argatroban plus alteplase according to time from onset to thrombolysis in acute ischemic stroke: a prespecified post-hoc analysis of the ARAIS trial
by: Yu Cui, et al.
Published: (2025-06-01)